Synbio Tech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	1,039	989.48	823.3	739.33
Revenue Growth (YoY)	4.97%	20.18%	11.36%	-
Cost of Revenue	483.47	448.64	404.56	378
Gross Profit	555.2	540.84	418.75	361.33
Selling, General & Admin	237.95	222.88	275.79	259.49
Research & Development	118.84	108.57	-	-
Operating Expenses	356.94	331.45	275.79	259.82
Operating Income	198.26	209.4	142.96	101.5
Interest Expense	-12.7	-3.71	-6.6	-7.69
Interest & Investment Income	9.54	9.27	7.34	6.54
Currency Exchange Gain (Loss)	-	-	-3.16	10.08
Other Non Operating Income (Expenses)	7.26	21.64	6.58	5.27
EBT Excluding Unusual Items	202.36	236.59	147.12	115.7
Gain (Loss) on Sale of Assets	-	-	-0.06	-
Pretax Income	202.36	236.59	147.07	115.7
Income Tax Expense	26.4	66.47	33.8	23.18
Net Income	175.97	170.13	113.27	92.52
Net Income to Common	175.97	170.13	113.27	92.52
Net Income Growth	3.44%	50.19%	22.43%	-
Shares Outstanding (Basic)	33	31	31	31
Shares Outstanding (Diluted)	33	32	31	31
Shares Change (YoY)	5.79%	0.02%	0.02%	-
EPS (Basic)	5.29	5.43	3.61	2.96
EPS (Diluted)	5.28	5.40	3.60	2.94
EPS Growth	-2.22%	50.08%	22.33%	-
Free Cash Flow	-559.72	-40.62	-113.36	-29.54
Free Cash Flow Per Share	-16.80	-1.29	-3.60	-0.94
Dividend Per Share	-	3.500	1.471	1.961
Dividend Growth	-	138.00%	-25.00%	-
Gross Margin	53.45%	54.66%	50.86%	48.87%
Operating Margin	19.09%	21.16%	17.36%	13.73%
Profit Margin	16.94%	17.19%	13.76%	12.51%
Free Cash Flow Margin	-53.89%	-4.11%	-13.77%	-4.00%
EBITDA	277.49	285.44	215.04	173.4
EBITDA Margin	26.72%	28.85%	26.12%	23.45%
D&A For EBITDA	79.23	76.04	72.08	71.9
EBIT	198.26	209.4	142.96	101.5
EBIT Margin	19.09%	21.16%	17.36%	13.73%
Effective Tax Rate	13.04%	28.09%	22.98%	20.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.